Psychiatry and Neurology, Neurology · Owosso, MI
NPI
1144483660
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
819 N Shiawassee St Ste 110
Owosso, MI, 48867
Phone (989) 723-1390
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
1,107 services
Medicare patients, 2024
151
Average age 61
Drug cost, 2024
$4.8M
4,040 prescriptions
Company payments, 2025
$74K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert J Pace was code 99214 (office e&m - established), 151 times for 95 patients. In total Robert J Pace billed 1,107 services in 21 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 151 | 95 | $61.92 | $9,349 |
| 99214 Office E&M - Established | Office | 49 | 36 | $56.77 | $2,782 |
By year: 2022 $19K for 501 services; 2023 $19K for 905 services; 2024 $19K for 1,107 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert J Pace prescribed most often to Medicare patients was Gabapentin, with 325 prescriptions and refills. In total Robert J Pace wrote 4,040 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 325 | 495 | 73 | $8,160 |
| Dalfampridine Er Dalfampridine | 322 | 446 | 51 | $128K |
| Baclofen Generic | 304 | 495 | 80 | $6,191 |
| Kesimpta Pen Ofatumumab | 284 | 295 | 28 | $2.5M |
| Pregabalin Generic | 183 | 237 | 36 | $3,301 |
| Modafinil Generic | 137 | 203 | 36 | $7,595 |
| Citalopram Hbr Citalopram Hydrobromide | 113 | 178 | 25 | $749 |
| Diazepam Generic | 107 | 123 | 26 | $985 |
| Duloxetine Hcl Generic | 82 | 158 | 19 | $1,737 |
| Topiramate Generic | 81 | 122 | 17 | $962 |
| Tizanidine Hcl Generic | 79 | 125 | 22 | $2,550 |
| Teriflunomide Generic | 70 | 78 | Under 11 | $85K |
| Lamotrigine Generic | 68 | 96 | Under 11 | $955 |
| Nortriptyline Hcl Generic | 65 | 75 | 12 | $561 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 65 | 119 | 17 | $910 |
Brand drugs: 683 claims; generic drugs: 3,357 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert J Pace $74K ($72K in general payments such as food, travel and fees and $2,493 for research) from 17 companies. The largest payer was EMD Serono, Inc. with $49K.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 45 | $49K |
| TG Therapeutics, Inc. TGTX | 20 | $14K |
| Biogen, Inc. BIIB | 8 | $6,299 |
| F. Hoffmann-La Roche AG ROG.SW | 1 | $2,493 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $2,310 |
| Abbvie Inc. ABBV | 17 | $162 |
| Genentech, Inc. ROG.SW | 1 | $120 |
| Celgene Corporation BMY | 4 | $76.26 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $54.65 |
| Genentech USA, Inc. ROG.SW | 1 | $46.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.